NUVATION BIO INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.335 USD | -1.04% |
|
+4.55% | +120.86% |
| 04-17 | RBC Raises Price Target on Nuvation Bio to $5 From $4, Keeps Outperform, Speculative Risk | MT |
| 04-10 | Nuvation Bio Closes Acquisition of AnHeart Therapeutics | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 885M | - | - | - | - | - | |
| 48.16B | - | |||||
| 41.73B | ||||||
| 41.03B | ||||||
| 28.77B | ||||||
| 25.59B |
- Stock Market
- Equities
- NUVB Stock
- Charts Nuvation Bio Inc.
- Sector Chart
